Engineered heparins: novel beta-secretase inhibitors as potential Alzheimer's disease therapeutics. (2008)
Attributed to:
Chemical intervention in heparan sulphate-dependent growth factor signalling systems using engineered heparin saccharides
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1159/000113701
PubMed Identifier: 18322389
Publication URI: http://europepmc.org/abstract/MED/18322389
Type: Journal Article/Review
Volume: 5
Parent Publication: Neuro-degenerative diseases
Issue: 3-4
ISSN: 1660-2854